Breast cancer genetics in African Americans

An overview of the state of genetic testing for BRCA1 and BRCA2 genes was presented at the Summit Meeting on Breast Cancer Among African American women.

[1]  O. Olopade,et al.  Male breast cancer in Cowden syndrome patients with germlinePTEN mutations , 2001, Journal of medical genetics.

[2]  J. Carpten,et al.  Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. , 2000, Annals of epidemiology.

[3]  C. Adebamowo,et al.  Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer , 2000, Human Genetics.

[4]  E. Gillanders,et al.  Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Olufunmilayo I. Olopade,et al.  Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer , 2000, Human Genetics.

[6]  C. Isaacs,et al.  Spiritual faith and genetic testing decisions among high-risk breast cancer probands. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  M. King,et al.  Insights into the functions of BRCA1 and BRCA2. , 2000, Trends in genetics : TIG.

[8]  A. Godwin,et al.  Novel germline BRCA1 mutation (155del4) in an African American with early‐onset breast cancer , 1999, Human mutation.

[9]  H. Mefford,et al.  Evidence for a BRCA1 founder mutation in families of West African ancestry. , 1999, American journal of human genetics.

[10]  R. Modali,et al.  BRCA1 mutations in African Americans , 1999, Human Genetics.

[11]  C. Adebamowo,et al.  Case‐controlled study of the epidemiological risk factors for breast cancer in Nigeria , 1999, The British journal of surgery.

[12]  I. Andrulis,et al.  Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. , 1999, Journal of the National Cancer Institute.

[13]  P. Underhill,et al.  Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. , 1999, Human molecular genetics.

[14]  E. Smith,et al.  Pattern of breast cancer among white-American, African-American, and nonimmigrant west-African women. , 1998, Journal of the National Medical Association.

[15]  S. Cummings,et al.  Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. King,et al.  Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. , 1998, American journal of human genetics.

[17]  M. King,et al.  Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. , 1998, JAMA.

[18]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[19]  J. Klijn,et al.  Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 , 1998, The Lancet.

[20]  W. Neufeld-Kaiser,et al.  Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors. , 1997, JAMA.

[21]  C. Isaacs,et al.  Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. , 1997, Patient education and counseling.

[22]  D. Page,et al.  BRCA1 and BRCA2 hereditary breast carcinoma phenotypes , 1997 .

[23]  P. Tonin,et al.  Brca2 hereditary breast cancer pathophenotype , 1997, Breast Cancer Research and Treatment.

[24]  M. Stratton.  Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.

[25]  F. Couch,et al.  BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. , 1997, The New England journal of medicine.

[26]  H. Mefford,et al.  BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. , 1997, American journal of human genetics.

[27]  P. Laurent-Puig,et al.  BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. , 1997, American journal of human genetics.

[28]  S. Cummings,et al.  Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. , 1997, American journal of human genetics.

[29]  H. Hanafusa,et al.  Evidence for a transcriptional activation function of BRCA1 C-terminal region. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Fiddler,et al.  Practice-based competencies for accreditation of and training in graduate programs in genetic counseling , 1996, Journal of Genetic Counseling.

[31]  J. Rommens,et al.  The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.

[32]  G M Lenoir,et al.  Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage , 1996, Cancer.

[33]  Robin L. Bennett,et al.  Recommendations for standardized human pedigree nomenclature , 1995, Journal of Genetic Counseling.

[34]  Francis S. Collins,et al.  Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer , 1994, Nature Genetics.

[35]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[36]  M. Skolnick,et al.  BRCA1 mutations in primary breast and ovarian carcinomas. , 1994, Science.

[37]  G. Palos.  Cultural heritage: cancer screening and early detection. , 1994, Seminars in oncology nursing.

[38]  C. Varricchio,et al.  Efforts to recruit the economically disadvantaged to national clinical trials. , 1994, Seminars in oncology nursing.

[39]  T. Ades,et al.  American Cancer Society urban demonstration projects: models for successful intervention. , 1994, Seminars in oncology nursing.

[40]  C. Redmond,et al.  Histological characteristics of breast carcinoma in blacks and whites. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  J. Vadgama,et al.  Mutation analysis of BRCA1 gene in African-American patients with breast cancer. , 2000, Journal of the National Medical Association.

[42]  M. West,et al.  Racial differences in breast carcinoma survival , 2000, Cancer.

[43]  L. Strong,et al.  TP53 mutation and haplotype analysis of two large African American families , 1999, Human mutation.

[44]  M. Stratton,et al.  The genetics of familial breast cancer and their practical implications. , 1994, European journal of cancer.

[45]  D. Easton.  The inherited component of cancer. , 1994, British medical bulletin.

[46]  A. Lippman,et al.  Prenatal Genetic Testing and Screening: Constructing Needs and Reinforcing Inequities , 2020, American Journal of Law & Medicine.

[47]  S. Kessler.  2 – The Psychological Foundations of Genetic Counseling , 1979 .